GUCY2D Molekülinformation
Molecule Name
Retinal guanylyl cyclase 1
Molekülalias
GUCY2D,Retinal guanylyl cyclase 1,RETGC-1,CORD6,GUC1A4,GUC2D,ROS-GC
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
RETGC-1，CG-E，Guanylate cyclase 2D， retinal，Rod outer segment membrane guanylate cyclase (ROS-GC)，CORD6，GUC1A4，GUC2D，RETGC，RETGC1
Molekülhintergrund
GUCY2D also known as CORD6, GUC1A4, GUC2D ROS-GC and RETGC-1, belongs to the adenylyl cyclase class-4/guanylyl cyclase family. Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment. May also participate in the trafficking of membrane-asociated proteins to the photoreceptor outer segment membrane.
GUCY2D Produktliste
You Have Viewed 0 Of 0 Results
Klinische Arzneimittelinformation
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| ATSN-101 | SAR-439483; ATSN-101 | Phase 2 Clinical | University Of Florida | Leber Congenital Amaurosis | Details |